Compile Data Set for Download or QSAR
maximum 50k data
Found 60 Enz. Inhib. hit(s) with all data for entry = 7383
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192452(US9187466, 50 | US9687476, 50)
Affinity DataIC50:  1.40nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192451(US9187466, 49 | US9687476, 49)
Affinity DataIC50:  1.5nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192449(US9187466, 32 | US9687476, 32)
Affinity DataIC50:  2nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192468(US10800746, Example WO 2011/104322 110 | US9187466...)
Affinity DataIC50:  3.30nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192450(US9187466, 42 | US9687476, 42)
Affinity DataIC50:  4nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192456(US9187466, 71 | US9687476, 71)
Affinity DataIC50:  4.20nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192467(US10800746, Example WO 2011/104322 101 | US9187466...)
Affinity DataIC50:  4.40nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192473(US9187466, 132 | US9687476, 132)
Affinity DataIC50:  4.60nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192474(US9187466, 135 | US9687476, 135)
Affinity DataIC50:  5.80nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192468(US10800746, Example WO 2011/104322 110 | US9187466...)
Affinity DataIC50:  6.5nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192453(US10800746, Example WO 2011/104322 54 | US9187466,...)
Affinity DataIC50:  6.80nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192469(US9187466, 111 | US9687476, 111)
Affinity DataIC50:  7.70nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192455(US10800746, Example WO 2011/104322 68 | US9187466,...)
Affinity DataIC50:  8.30nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192466(US9187466, 96 | US9687476, 96)
Affinity DataIC50:  8.40nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192453(US10800746, Example WO 2011/104322 54 | US9187466,...)
Affinity DataIC50:  8.5nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192449(US9187466, 32 | US9687476, 32)
Affinity DataIC50:  8.60nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192450(US9187466, 42 | US9687476, 42)
Affinity DataIC50:  11nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192463(US9187466, 87 | US9687476, 87)
Affinity DataIC50:  12nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192454(US10800746, Example WO 2011/104322 60 | US9187466,...)
Affinity DataIC50:  12nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192455(US10800746, Example WO 2011/104322 68 | US9187466,...)
Affinity DataIC50:  12nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192456(US9187466, 71 | US9687476, 71)
Affinity DataIC50:  13nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192458(US9187466, 76 | US9687476, 76)
Affinity DataIC50:  17nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192451(US9187466, 49 | US9687476, 49)
Affinity DataIC50:  19nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192448(US9187466, 26 | US9687476, 26)
Affinity DataIC50:  23nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192458(US9187466, 76 | US9687476, 76)
Affinity DataIC50:  23nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192459(US9187466, 78 | US9687476, 78)
Affinity DataIC50:  23nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192445(US9187466, 9 | US9687476, 9)
Affinity DataIC50:  23nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192467(US10800746, Example WO 2011/104322 101 | US9187466...)
Affinity DataIC50:  27nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192472(US9187466, 122 | US9687476, 122)
Affinity DataIC50:  27nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192448(US9187466, 26 | US9687476, 26)
Affinity DataIC50:  28nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192459(US9187466, 78 | US9687476, 78)
Affinity DataIC50:  29nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192469(US9187466, 111 | US9687476, 111)
Affinity DataIC50:  31nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192446(US9187466, 17 | US9687476, 17)
Affinity DataIC50:  32nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192452(US9187466, 50 | US9687476, 50)
Affinity DataIC50:  34nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192471(US9187466, 117 | US9687476, 117)
Affinity DataIC50:  39nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192457(US9187466, 74 | US9687476, 74)
Affinity DataIC50:  40nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192471(US9187466, 117 | US9687476, 117)
Affinity DataIC50:  45nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192447(US9187466, 20 | US9687476, 20)
Affinity DataIC50:  46nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192454(US10800746, Example WO 2011/104322 60 | US9187466,...)
Affinity DataIC50:  50nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192445(US9187466, 9 | US9687476, 9)
Affinity DataIC50:  60nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192460(US9187466, 83 | US9687476, 83)
Affinity DataIC50:  67nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192464(US9187466, 90 | US9687476, 90)
Affinity DataIC50:  88nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192465(US9187466, 93 | US9687476, 93)
Affinity DataIC50:  89nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192465(US9187466, 93 | US9687476, 93)
Affinity DataIC50:  100nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192470(US9187466, 112 | US9687476, 112)
Affinity DataIC50:  110nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192466(US9187466, 96 | US9687476, 96)
Affinity DataIC50:  120nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192446(US9187466, 17 | US9687476, 17)
Affinity DataIC50:  120nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192447(US9187466, 20 | US9687476, 20)
Affinity DataIC50:  150nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192460(US9187466, 83 | US9687476, 83)
Affinity DataIC50:  230nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192457(US9187466, 74 | US9687476, 74)
Affinity DataIC50:  260nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 60 total ) | Next | Last >>
Jump to: